Skip to main content

Table 1 Demographics of PLT and CLD patients

From: Health-related quality of life in pediatric liver transplanted patients compared with a chronic liver disease group

 

PLT group

CLD group

P

Number of subjects

33

25

-

Gender, M(%)-F(%)

19 (58%) – 14 (41%)

13 (51%) -12 (49%)

0.79

Age

(range, mean, sd) (years)

6.2-18.0;12.8; sd ± 3.6

6.6-18.0; 11.9 yrs; sd ± 3.0

0.316

Age at transplantation (range, mean, sd) (years)

0.2-12.5; 3.5; sd ± 3.7

-

 

Avg time elapsed from PLT (mean, sd) (years)

12.1; sd ± 4.3

-

 

Average rate hospitalization (admissions/year) (mean, sd)

7.9; sd ± 3.7

Mean 2.9; sd ± 1.06

0.0001

Race (language)

Caucasian (Italian)

Caucasian (Italian)

 

Indications for liver transplant

Biliary atresia (n = 29); Metabolic liver disease (n = 2); Autoimmune hepatitis (n = 1); Hepatoblastoma (n = 1)

-

 

Type of chronic liver disease

-

Chronic viral or autoimmune hepatitis (n = 13); Wilson’s disease (n = 6); Cryptogenic chronic hepatopathy (n = 5); Others (n = 1).

 
  1. PLT pediatric Liver Transplant group, CLD chronic Liver Disease group.